UniProt ID | AT8B1_HUMAN | |
---|---|---|
UniProt AC | O43520 | |
Protein Name | Phospholipid-transporting ATPase IC | |
Gene Name | ATP8B1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1251 | |
Subcellular Localization |
Cell membrane Multi-pass membrane protein. Apical cell membrane . Cell projection, stereocilium . Endoplasmic reticulum . Golgi apparatus . Exit from the endoplasmic reticulum requires the presence of TMEM30A or TMEM30B (PubMed:20947505). Localizes |
|
Protein Description | Catalytic component of a P4-ATPase flippase complex which catalyzes the hydrolysis of ATP coupled to the transport of aminophospholipids from the outer to the inner leaflet of various membranes and ensures the maintenance of asymmetric distribution of phospholipids. Phospholipid translocation seems also to be implicated in vesicle formation and in uptake of lipid signaling molecules. May play a role in asymmetric distribution of phospholipids in the canicular membrane. May have a role in transport of bile acids into the canaliculus, uptake of bile acids from intestinal contents into intestinal mucosa or both. In cooperation with ABCB4 may be involved in establishing integrity of the canalicular membrane thus protecting hepatocytes from bile salts. Together with TMEM30A is involved in uptake of the synthetic drug alkylphospholipid perifosine. Involved in the microvillus formation in polarized epithelial cells; the function seems to be independent from its flippase activity. Required for the preservation of cochlear hair cells in the inner ear. May act as cardiolipin transporter during inflammatory injury.. | |
Protein Sequence | MSTERDSETTFDEDSQPNDEVVPYSDDETEDELDDQGSAVEPEQNRVNREAEENREPFRKECTWQVKANDRKYHEQPHFMNTKFLCIKESKYANNAIKTYKYNAFTFIPMNLFEQFKRAANLYFLALLILQAVPQISTLAWYTTLVPLLVVLGVTAIKDLVDDVARHKMDKEINNRTCEVIKDGRFKVAKWKEIQVGDVIRLKKNDFVPADILLLSSSEPNSLCYVETAELDGETNLKFKMSLEITDQYLQREDTLATFDGFIECEEPNNRLDKFTGTLFWRNTSFPLDADKILLRGCVIRNTDFCHGLVIFAGADTKIMKNSGKTRFKRTKIDYLMNYMVYTIFVVLILLSAGLAIGHAYWEAQVGNSSWYLYDGEDDTPSYRGFLIFWGYIIVLNTMVPISLYVSVEVIRLGQSHFINWDLQMYYAEKDTPAKARTTTLNEQLGQIHYIFSDKTGTLTQNIMTFKKCCINGQIYGDHRDASQHNHNKIEQVDFSWNTYADGKLAFYDHYLIEQIQSGKEPEVRQFFFLLAVCHTVMVDRTDGQLNYQAASPDEGALVNAARNFGFAFLARTQNTITISELGTERTYNVLAILDFNSDRKRMSIIVRTPEGNIKLYCKGADTVIYERLHRMNPTKQETQDALDIFANETLRTLCLCYKEIEEKEFTEWNKKFMAASVASTNRDEALDKVYEEIEKDLILLGATAIEDKLQDGVPETISKLAKADIKIWVLTGDKKETAENIGFACELLTEDTTICYGEDINSLLHARMENQRNRGGVYAKFAPPVQESFFPPGGNRALIITGSWLNEILLEKKTKRNKILKLKFPRTEEERRMRTQSKRRLEAKKEQRQKNFVDLACECSAVICCRVTPKQKAMVVDLVKRYKKAITLAIGDGANDVNMIKTAHIGVGISGQEGMQAVMSSDYSFAQFRYLQRLLLVHGRWSYIRMCKFLRYFFYKNFAFTLVHFWYSFFNGYSAQTAYEDWFITLYNVLYTSLPVLLMGLLDQDVSDKLSLRFPGLYIVGQRDLLFNYKRFFVSLLHGVLTSMILFFIPLGAYLQTVGQDGEAPSDYQSFAVTIASALVITVNFQIGLDTSYWTFVNAFSIFGSIALYFGIMFDFHSAGIHVLFPSAFQFTGTASNALRQPYIWLTIILAVAVCLLPVVAIRFLSMTIWPSESDKIQKHRKRLKAEEQWQRRQQVFRRGVSTRRSAYAFSHQRGYADLISSGRSIRKKRSPLDAIVADGTAEYRRTGDS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
15 | Phosphorylation | ETTFDEDSQPNDEVV CCCCCCCCCCCCCCC | 45.55 | 28348404 | |
24 | Phosphorylation | PNDEVVPYSDDETED CCCCCCCCCCCCCCC | 17.08 | 28348404 | |
25 | Phosphorylation | NDEVVPYSDDETEDE CCCCCCCCCCCCCCC | 32.30 | 29802988 | |
29 | Phosphorylation | VPYSDDETEDELDDQ CCCCCCCCCCCCCCC | 56.59 | 29802988 | |
38 | Phosphorylation | DELDDQGSAVEPEQN CCCCCCCCCCCHHHH | 24.41 | 28348404 | |
60 | Methylation | ENREPFRKECTWQVK HHCCCCHHHCCEEEE | 58.48 | 23644510 | |
417 | Ubiquitination | VIRLGQSHFINWDLQ EEECCCCEEECCEEE | 21.51 | 22817900 | |
438 | Phosphorylation | DTPAKARTTTLNEQL CCCCCCCCCCHHHHH | 29.06 | 29759185 | |
439 | Phosphorylation | TPAKARTTTLNEQLG CCCCCCCCCHHHHHC | 24.59 | 29759185 | |
440 | Phosphorylation | PAKARTTTLNEQLGQ CCCCCCCCHHHHHCC | 27.29 | 29759185 | |
455 | Ubiquitination | IHYIFSDKTGTLTQN EEEEEECCCCCEECC | 47.89 | 22817900 | |
476 | Phosphorylation | CCINGQIYGDHRDAS HEECCEECCCCCCCH | 14.49 | - | |
584 | Phosphorylation | ITISELGTERTYNVL EEEECCCCCCEEEEE | 34.61 | 24719451 | |
609 | Phosphorylation | RMSIIVRTPEGNIKL EEEEEEECCCCCEEE | 18.13 | 29396449 | |
615 | Methylation | RTPEGNIKLYCKGAD ECCCCCEEEEECCCC | 37.09 | - | |
639 | Ubiquitination | MNPTKQETQDALDIF CCCCCCHHHHHHHHH | 29.29 | 29901268 | |
658 | Phosphorylation | LRTLCLCYKEIEEKE HHHHHHHHHHHHHHH | 9.94 | - | |
667 | Phosphorylation | EIEEKEFTEWNKKFM HHHHHHCHHHHHHHH | 40.98 | 24719451 | |
689 | Ubiquitination | NRDEALDKVYEEIEK CHHHHHHHHHHHHHH | 47.79 | 29901268 | |
779 | Phosphorylation | QRNRGGVYAKFAPPV CCCCCCCCCCCCCCC | 13.83 | - | |
789 | Phosphorylation | FAPPVQESFFPPGGN CCCCCCCCCCCCCCC | 18.33 | - | |
902 | Acetylation | ANDVNMIKTAHIGVG CCCCCEEEEEEEECC | 28.96 | 19825509 | |
924 | Phosphorylation | QAVMSSDYSFAQFRY HHHHCCCCCHHHHHH | 13.98 | - | |
925 | Phosphorylation | AVMSSDYSFAQFRYL HHHCCCCCHHHHHHH | 21.06 | - | |
931 | Phosphorylation | YSFAQFRYLQRLLLV CCHHHHHHHHHHHHH | 14.42 | 26074081 | |
992 | Phosphorylation | ITLYNVLYTSLPVLL HHHHHHHHHHHHHHH | 7.04 | - | |
1012 | Phosphorylation | QDVSDKLSLRFPGLY CCCCHHHCCCCCCEE | 24.20 | 24719451 | |
1173 | Phosphorylation | LSMTIWPSESDKIQK HHCCCCCCCHHHHHH | 34.43 | 29759185 | |
1175 | Phosphorylation | MTIWPSESDKIQKHR CCCCCCCHHHHHHHH | 48.84 | 29759185 | |
1203 | Phosphorylation | QVFRRGVSTRRSAYA HHHHHCCCHHHHHHH | 21.01 | 24719451 | |
1204 | Phosphorylation | VFRRGVSTRRSAYAF HHHHCCCHHHHHHHH | 27.91 | - | |
1207 | Phosphorylation | RGVSTRRSAYAFSHQ HCCCHHHHHHHHCCC | 23.49 | 25849741 | |
1209 | Phosphorylation | VSTRRSAYAFSHQRG CCHHHHHHHHCCCCC | 14.93 | 23911959 | |
1212 | Phosphorylation | RRSAYAFSHQRGYAD HHHHHHHCCCCCHHH | 15.56 | 29038488 | |
1217 | Phosphorylation | AFSHQRGYADLISSG HHCCCCCHHHHHHCC | 10.11 | 27273156 | |
1222 | Phosphorylation | RGYADLISSGRSIRK CCHHHHHHCCCCCCC | 33.75 | 25849741 | |
1223 | Phosphorylation | GYADLISSGRSIRKK CHHHHHHCCCCCCCC | 31.09 | 26356563 | |
1226 | Phosphorylation | DLISSGRSIRKKRSP HHHHCCCCCCCCCCC | 30.21 | 23312004 | |
1232 | Phosphorylation | RSIRKKRSPLDAIVA CCCCCCCCCCHHEEE | 38.40 | 23312004 | |
1242 | Phosphorylation | DAIVADGTAEYRRTG HHEEECCCHHHHCCC | 19.50 | - | |
1245 | Phosphorylation | VADGTAEYRRTGDS- EECCCHHHHCCCCC- | 11.70 | 27259358 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AT8B1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AT8B1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AT8B1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CC50A_HUMAN | TMEM30A | physical | 21914794 | |
CC50B_HUMAN | TMEM30B | physical | 21914794 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00624 | Familial cholestasis, including: Progressive familial intrahepatic cholestasis (PFIC); Benign recurr | |||||
OMIM Disease | ||||||
211600 | Cholestasis, progressive familial intrahepatic, 1 (PFIC1) | |||||
243300 | Cholestasis, benign recurrent intrahepatic, 1 (BRIC1) | |||||
147480 | Cholestasis of pregnancy, intrahepatic 1 (ICP1) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1217, AND MASSSPECTROMETRY. |